HPV vaccine

papillomavirus (HPV) is a sexually transmitted disease and is the second most common cause of cancer among women. HPV is group of viruses that causes warts on mucosal surfaces like the cervix, rectum, anus, penis, vulva, and mouth or throat. This condition is associated with ovarian cancer, anal cancer, and oropharyngeal cancer. According to CDC, “the HPV vaccine is recommended for preteen boys and girls at age 11 or 12 so they are protected before ever being exposed to the virus” (CDC, n.d). The vaccine is

presented in tables for comparison and interpretation. Titles, legends accurately describe the content. Results RR (95%CI) or M ± SD. RR (95%CI) = relative risk (95% confidence intervals) where RR >1 indicates higher and RR < 1 indicates lower HPV vaccine acceptance. M ± SD = mean ± standard deviation. Intervention: 5.9 ± 3.1, Comparison: 5.7 ± 2.7. No p value was provided. Pre-intervention: 5.8 ± 3.0, Post-intervention:

(Smith, 2008). The Human Papillomavirus (HPV) is the most sexually transmitted disease in the world (Nath &Thappa, 2009). Four main strains of HPV exists, 6,11,16 and 18 (Smith, 2008). HPV strains 16 and 18 are the causative factors for 70% of the cervical cancers (Smith, 2008). HPV strains 6 and 11 cause about 90% of genital warts (Smith, 2008). Without serious side effects the Human Papillomavirus (HPV) Vaccine is 100% effective in preventing the two HPV strains that cause the largest percentages

HPV is by far the most common sexually transmitted infection in the United States. Per the Centers for Disease Control and Prevention (CDC), 50 percent of all sexually active men and women will get it at some point in their lives, and 20 million already have it. A vaccine is available that prevents 70% of cervical cancers that arise from sexual intercourse. The human papillomavirus is unknowingly common and is diagnosed in 10,000 women a year, causing 4,000 deaths per year (“HPV Question and Answers”)

Most adolescents 9 through 14 years of age should get HPV vaccine as a two-dose series with the doses separated by 6-12 months. People who start HPV vaccination at 15 years of age and older should get the vaccine as a three-dose series with the second dose given 1-2 months after the first dose and the third dose given 6 months after the first dose. There are several exceptions to these age recommendations. The vaccine produces better immunity to fight infection when given

What is HPV ? HPV is an acronym for Human Papillomaviruses , which is a group of over 150 different viruses . It is a sexually transmitted disease , that affects about 14 million people annually , usually people who are 20 - 25 . Where about 39,800 of those people have developed HPV associated cancers . HPV does not show specific signs or symptoms , making it easier for people to infect each other ( because they are unaware ) as well as making it harder to treat before it is too late . HPV causes

Safety of the HPV Vaccine There have been concerns about the safety of the HPV vaccines. In Basu’s (2013) article they reviewed the evidence from the phase III trials and national programs for the HPV vaccine. After reviewing the data though the article showed that all the randomized control trials reported both their serious and non-serious adverse events that took place during the phase III trials. “There were 20,000 participants in the trial” (p.4). Pain at the injection site, headache, and

Josie Caskey Honors Rhetoric Dr. Margaret Murray 20 April 2015 Should HPV Vaccines Be Mandatory? The debate over the human papillomavirus (HPV) vaccines represents two very controversial topics in healthcare in America, mandatory vaccination and teenage sexuality. Currently the two approved vaccines, Gardasil and Ceravix, are designed to protect against the sexually transmitted virus HPV. Because these vaccines have their greatest benefit when given before a person becomes sexually active, the

The benefits of receiving the HPV vaccine is according to the CDC (2017) is that it prevents genital warts and cancer is sexually active individuals. This is highly important because the infection of HPV can lead to cancer in the individual. According to the NIH National Cancer Institute (2016), states that all three of the available HPV vaccines that are out on todays market prevent HPV infection on HPV type 16 and 18. These two types of HPV are considered to be at extremely high risk for cervical

including the the dependent variable the HPV vaccine education and the independent variable enhancing knowledge and attitudes.The traditional abstract clearly and briefly outlines the main highlights of the report including the problem, methods, result and conclusion. The problem is focusing on parents of preadolescents with educational attempts that may aid them in making knowledgeable choices about vaccinating their children against the human papillomavirus (HPV). The methods used include a pilot study